Target intelligence / Profile preview

Gram-negative bacterial surface antigens

Molecular classification
Surface antigen, Lipopolysaccharide, Outer membrane protein, Glycolipid, Porin
01

Overview

Gram-negative bacterial surface antigens are a diverse array of molecules located on the outer membrane of Gram-negative bacteria, primarily consisting of lipopolysaccharides (LPS), outer membrane proteins (OMPs), and porins (Source: NCBI Bookshelf). These antigens are fundamental to bacterial survival, serving as a protective barrier against environmental stressors and facilitating the transport of essential nutrients (Source: Nature Reviews Microbiology). LPS, a hallmark of Gram-negative bacteria, acts as a potent endotoxin that can trigger systemic inflammatory response syndrome (SIRS) and septic shock by activating host immune pathways such as Toll-like receptor 4 (Source: PubMed). Due to their surface exposure, these molecules are primary targets for the development of antibacterial vaccines and monoclonal antibodies aimed at neutralizing toxins or promoting bacterial opsonization (Source: Frontiers in Immunology). Additionally, certain classes of antibiotics, such as polymyxins, exert their bactericidal effects by directly binding to and disrupting the LPS layer of the outer membrane (Source: Journal of Clinical Investigation).

Other names
Gram-negative cell wall antigensOuter membrane antigensGram-negative surface proteinsBacterial surface molecules
02

Mechanism of action

Binding and neutralization of endotoxins (LPS), disruption of outer membrane integrity, and opsonization to facilitate phagocytic clearance by the host immune system.

03

Biological functions

Cell wall integrityAdhesionNutrient transportImmune evasionEndotoxin activityMotility
04

Disease associations

InfectionSepsisPneumoniaUrinary tract infectionMeningitis
05

Safety considerations

Jarisch-Herxheimer reactionCytokine stormNephrotoxicityNeurotoxicityEndotoxin release upon bacterial lysis
06

Interacting drugs

Polymyxin B

5 more in the full profile.

07

Biomarkers

Endotoxin levelsProcalcitoninC-reactive proteinSpecific antibody titers

Beyond the preview

Go deeper on Gram-negative bacterial surface antigens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gram-negative bacterial surface antigens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call